Sign up to save your podcasts
Or
Share Beyond Ozempic: Why Silicon Valley Is Turning to Experimental Peptides
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Beyond Ozempic: Why Silicon Valley Is Turning to Experimental Peptides
Jasmine Sun on unregulated peptides moving from fringe biohacking to Silicon Valley mainstream, promising healing, focus, and optimization with little oversight
View all episodes
By Jasmine Sun on unregulated peptides moving from fringe biohacking to Silicon Valley mainstream, promising healing, focus, and optimization with little oversight